Cargando…

V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) as a prognostic biomarker of poor outcomes in esophageal cancer patients

BACKGROUND: Esophageal cancer is one of the most aggressive malignancies, and is associated with multiple genetic mutations. At present, the v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) gene mutation has been observed in esophageal cancer and is associated with poor prognosis. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuerbanjiang, Aihemaijiang, Maimaituerxun, Maimaitiyiming, Zhang, Yanjun, Li, Yiliang, Cui, Gang, Abuduhabaier, Aibaidula, Aierken, Abuduwaili, Miranbieke, Buya, Anzaer, Meilikezati, Maimaiti, Yusufu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903799/ https://www.ncbi.nlm.nih.gov/pubmed/33622273 http://dx.doi.org/10.1186/s12876-021-01671-2

Ejemplares similares

Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)(V600E) Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis
por: Yokomichi, Hiroshi, et al.
Publicado: (2020)

RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF
por: Poulikakos, Poulikos I., et al.
Publicado: (2010)

Interactome dynamics of RAF1-BRAF kinase monomers and dimers
por: Iglesias-Martinez, Luis F., et al.
Publicado: (2023)

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report
por: Stenman, Adam, et al.
Publicado: (2021)

Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
por: Chatelle, Claire V., et al.
Publicado: (2016)

BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors
por: Schreck, Karisa C., et al.
Publicado: (2019)

RAF inhibitor PLX8394 selectively disrupts BRAF-dimers and RAS-independent BRAF mutant-driven signaling
por: Yao, Zhan, et al.
Publicado: (2018)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021)

The stability of R-spine defines RAF inhibitor resistance: A comprehensive analysis of oncogenic BRAF mutants with in-frame insertion of αC-β4 loop
por: Yap, Jiajun, et al.
Publicado: (2021)

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
por: Poulikakos, Poulikos I., et al.
Publicado: (2011)

Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
por: Saei, Azad, et al.
Publicado: (2018)

B‐raf Oncogene: Activation by Rearrangements and Assignment to Human Chromosome 7
por: Kamiyama, Takashi, et al.
Publicado: (1993)

Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling
por: Nolan, Aoife A., et al.
Publicado: (2021)

Copper is required for oncogenic BRAF signaling and tumorigenesis
por: Brady, Donita C., et al.
Publicado: (2014)

Targeting Oncogenic BRAF: Past, Present, and Future
por: Zaman, Aubhishek, et al.
Publicado: (2019)

Oncogenic BRAF Alterations and Their Role in Brain Tumors
por: Behling, Felix, et al.
Publicado: (2019)

Acetylation-dependent regulation of BRAF oncogenic function
por: Dai, Xiangpeng, et al.
Publicado: (2022)

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
por: Bollag, Gideon, et al.
Publicado: (2010)

Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer
por: Pan, Jing-hua, et al.
Publicado: (2018)

Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition
por: Allen, Amy, et al.
Publicado: (2019)

An amino-terminal BRAF deletion accounting for acquired resistance to RAF/EGFR inhibition in colorectal cancer
por: Tung, Jack K., et al.
Publicado: (2020)

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
por: Clerk, Angela, et al.
Publicado: (2022)

Autophagy-Dependent Survival of Mutant B-Raf Melanoma Cells Selected for Resistance to Apoptosis Induced by Inhibitors against Oncogenic B-Raf
por: Ahn, Jun-Ho, et al.
Publicado: (2013)

Oncogenic Raf-1 Disrupts Epithelial Tight Junctions via Downregulation of Occludin
por: Li, Danxi, et al.
Publicado: (2000)

Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
por: Girotti, Maria Romina, et al.
Publicado: (2015)

Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma
por: Girotti, Maria Romina, et al.
Publicado: (2017)

Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAF(V600E)-Mutant Human Glioma
por: Schreck, Karisa C., et al.
Publicado: (2021)

Epigenetic Mechanisms of Escape from BRAF Oncogene Dependency
por: Khaliq, Mehwish, et al.
Publicado: (2019)

Clinical associations and genetic interactions of oncogenic BRAF alleles
por: Wagner, Sebastian A.
Publicado: (2022)

Analysis of the oncogene BRAF mutation and the correlation of the expression of wild-type BRAF and CREB1 in endometriosis
por: Lv, Xiao, et al.
Publicado: (2018)

Amplification of Both c‐myc and c‐raf‐1 Oncogenes in a Human Osteosarcoma
por: Ikeda, Shogo, et al.
Publicado: (1989)

Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation
por: Zaharie, Florin, et al.
Publicado: (2015)

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells
por: Molnár, Eszter, et al.
Publicado: (2018)

RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017)

Contribution of the BRAF oncogene in the pre-operative phase of thyroid carcinoma
por: RODRIGUES, HOMERO GUSTAVO CORREIA, et al.
Publicado: (2013)

ERK5 is activated by oncogenic BRAF and promotes melanoma growth
por: Tusa, Ignazia, et al.
Publicado: (2018)

The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants
por: Yuan, Jimin, et al.
Publicado: (2018)

Germline mutations of B-Raf proto-oncogene and pathological implications in prostate cancer: observational study
por: Tiabi, Ikram, et al.
Publicado: (2023)

Knockdown of 15-bp Deletion-Type v-raf Murine Sarcoma Viral Oncogene Homolog B1 mRNA in Pancreatic Ductal Adenocarcinoma Cells Repressed Cell Growth In Vitro and Tumor Volume In Vivo
por: Song, Jiaxuan, et al.
Publicado: (2022)

Sorting and decoration of semiconducting single-walled carbon nanotubes via the quaternization reaction
por: Luo, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ek1s2ne1pvi9akrabi7dv6u1us